144 related articles for article (PubMed ID: 11027330)
1. Intercellular delivery of a herpes simplex virus VP22 fusion protein from cells infected with lentiviral vectors.
Lai Z; Han I; Zirzow G; Brady RO; Reiser J
Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11297-302. PubMed ID: 11027330
[TBL] [Abstract][Full Text] [Related]
2. Gene transfer into the central nervous system in vivo using a recombinanat lentivirus vector.
Lai Z; Brady RO
J Neurosci Res; 2002 Feb; 67(3):363-71. PubMed ID: 11813241
[TBL] [Abstract][Full Text] [Related]
3. VP22 and cytosine deaminase fusion gene modified tissue-engineered neural stem cells for glioma therapy.
Jin G; Zhou Y; Chai Q; Zhu G; Xu F; Liu F
J Cancer Res Clin Oncol; 2013 Mar; 139(3):475-83. PubMed ID: 23180018
[TBL] [Abstract][Full Text] [Related]
4. The study of the intercellular trafficking of the fusion proteins of herpes simplex virus protein VP22.
Xue X; Huang J; Wang H
PLoS One; 2014; 9(6):e100840. PubMed ID: 24955582
[TBL] [Abstract][Full Text] [Related]
5. Engineered cell therapy for sustained local myocardial delivery of nonsecreted proteins.
Bian J; Kiedrowski M; Mal N; Forudi F; Penn MS
Cell Transplant; 2006; 15(1):67-74. PubMed ID: 16700331
[TBL] [Abstract][Full Text] [Related]
6. VP22 does not significantly enhance enzyme prodrug cancer gene therapy as a part of a VP22-HSVTk-GFP triple fusion construct.
Hakkarainen T; Wahlfors T; Meriläinen O; Loimas S; Hemminki A; Wahlfors J
J Gene Med; 2005 Jul; 7(7):898-907. PubMed ID: 15759279
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of lentivirus-mediated and MUC1 antibody-targeted VP22-TK/GCV suicide gene therapy for ovarian cancer.
Kong B; Wang W; Liu C; Song L; Ma D; Qu X; Jiang J; Yang X; Zhang Y; Wang B; Wei MQ; Yang Q
In Vivo; 2003; 17(2):153-6. PubMed ID: 12792977
[TBL] [Abstract][Full Text] [Related]
8. Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22.
Dilber MS; Phelan A; Aints A; Mohamed AJ; Elliott G; Smith CI; O'Hare P
Gene Ther; 1999 Jan; 6(1):12-21. PubMed ID: 10341871
[TBL] [Abstract][Full Text] [Related]
9. Enhanced suicide gene effect by adenoviral transduction of a VP22-cytosine deaminase (CD) fusion gene.
Wybranietz WA; Gross CD; Phelan A; O'Hare P; Spiegel M; Graepler F; Bitzer M; Stähler P; Gregor M; Lauer UM
Gene Ther; 2001 Nov; 8(21):1654-64. PubMed ID: 11895004
[TBL] [Abstract][Full Text] [Related]
10. Mapping of herpes simplex virus-1 VP22 functional domains for inter- and subcellular protein targeting.
Aints A; Güven H; Gahrton G; Smith CI; Dilber MS
Gene Ther; 2001 Jul; 8(14):1051-6. PubMed ID: 11526452
[TBL] [Abstract][Full Text] [Related]
11. Induction of insolubility by herpes simplex virus VP22 precludes intercellular trafficking of N-terminal Apoptin-VP22 fusion proteins.
Rutjes SA; Bosma PJ; Rohn JL; Noteborn MH; Wesseling JG
J Mol Med (Berl); 2003 Sep; 81(9):558-65. PubMed ID: 12879152
[TBL] [Abstract][Full Text] [Related]
12. VP22 enhances the expression of glucocerebrosidase in human Gaucher II fibroblast cells mediated by lentiviral vectors.
Jin GS; Zhu GD; Zhao ZG; Liu FS
Clin Exp Med; 2012 Sep; 12(3):135-43. PubMed ID: 21874584
[TBL] [Abstract][Full Text] [Related]
13. Evidence for intercellular trafficking of VP22 in living cells.
Lemken ML; Wolf C; Wybranietz WA; Schmidt U; Smirnow I; Bühring HJ; Mack AF; Lauer UM; Bitzer M
Mol Ther; 2007 Feb; 15(2):310-9. PubMed ID: 17235309
[TBL] [Abstract][Full Text] [Related]
14. Intercellular trafficking of VP22-GFP fusion proteins is not observed in cultured mammalian cells.
Fang B; Xu B; Koch P; Roth JA
Gene Ther; 1998 Oct; 5(10):1420-4. PubMed ID: 9930348
[TBL] [Abstract][Full Text] [Related]
15. Intercellular trafficking of VP22, a herpes simplex virus type 1 tegument protein.
Bamdad T; Bell JC
Iran Biomed J; 2007 Jan; 11(1):53-7. PubMed ID: 18051705
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral spread and increased efficacy of a p53-VP22 fusion protein expressed by a recombinant adenovirus.
Wills KN; Atencio IA; Avanzini JB; Neuteboom S; Phelan A; Philopena J; Sutjipto S; Vaillancourt MT; Wen SF; Ralston RO; Johnson DE
J Virol; 2001 Sep; 75(18):8733-41. PubMed ID: 11507218
[TBL] [Abstract][Full Text] [Related]
17. Of the three tegument proteins that package mRNA in herpes simplex virions, one (VP22) transports the mRNA to uninfected cells for expression prior to viral infection.
Sciortino MT; Taddeo B; Poon AP; Mastino A; Roizman B
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8318-23. PubMed ID: 12060774
[TBL] [Abstract][Full Text] [Related]
18. Efficient gene transfer to human peripheral blood monocyte-derived dendritic cells using human immunodeficiency virus type 1-based lentiviral vectors.
Chinnasamy N; Chinnasamy D; Toso JF; Lapointe R; Candotti F; Morgan RA; Hwu P
Hum Gene Ther; 2000 Sep; 11(13):1901-9. PubMed ID: 10986562
[TBL] [Abstract][Full Text] [Related]
19. The enhanced efficacy of herpes simplex virus by lentivirus mediated VP22 and cytosine deaminase gene therapy against glioma.
Mi R; Fan W; Ji J; Dong C; Jin G; Liu F
Brain Res; 2020 Sep; 1743():146898. PubMed ID: 32439343
[TBL] [Abstract][Full Text] [Related]
20. Fusion of HSV-1 VP22 to a bifunctional chimeric SuperCD suicide gene compensates for low suicide gene transduction efficiencies.
Lemken ML; Graepler F; Wolf C; Wybranietz WA; Smirnow I; Schmidt U; Gregor M; Bitzer M; Lauer UM
Int J Oncol; 2007 May; 30(5):1153-61. PubMed ID: 17390017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
